GLNG & BMRN Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Upcoming Lead Plaintiff Deadlines
November 18, 2020 at 11:00 AM EST
NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Golar LNG Limited (NASDAQ: GLNG)
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)